Refine by
Seeding Articles & Analysis: Older
117 news found
This interview provides insight into Clean Cells’ quest to automate and increase single-cell seeding while having undisputable proof of clonality even in GMP settings. ...
Steroids offered by Alfa Chemistry are derived from vegetable oils, nuts, and seeds. These compounds are notable for their pharmacological activity, particularly in the treatment of heart diseases and various cancers. ...
LBG is a neutral polysaccharide composed of mannose and galactose units and is a galactomannan. It is extracted from the seeds of the carob tree (Ceratonia siliqua), which is abundant in the Mediterranean region, although its distribution also extends to various parts of North Africa, South America and Asia. There are several synonyms for this polysaccharide, such as such as ...
Pak said she has funded development of the technology through $4.3 million in non-dilutive research grants, and LynxBio is now in the process of raising $1.25 million in seed funding.. Read more ...
$5.5M financing led by Taiho Ventures LLC, with participation of existing investors, including the Series Seed lead, Kizoo Technology Capital GmbH Fresh capital to be employed to get cellvie Series A ready by accelerating the development of the company's technology platform, strengthening the team, and advancing the mitochondria's GMP manufacturing cellvie Inc., a leader in ...
VeriSIM Life has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $255,908 to conduct research and development (R&D) work on rapid repurposing and translation of approved and investigational drugs for COVID-19 using its patented artificial intelligence (AI) driven biosimulation platform, BIOiSIM. VeriSIM Life has developed a whole-body ...
In 2019, 4D Path successfully closed a ~USD 4.4M funding round with the Seed Three Convertible Preferred Stock offering, bringing their total funds raised to $6.4M. ...
April 8, 2022; OSLO, Norway/ TOKYO, Japan: CEPI, the Coalition for Epidemic Preparedness Innovations, and NEC Corporation (NEC: TSE: 6701) today announced the latest funding award under its US$200m programme to advance the development of vaccines that provide broad protection against SARS-CoV-2 variants and other betacoronaviruses[1]. CEPI will provide seed funding of up to ...
With nearly $24 billion in cumulative committed capital since the firm’s founding in 1977, NEA invests in technology and healthcare companies at all stages in a company’s lifecycle, from seed stage through IPO. The firm’s track record of investing includes more than 260 portfolio company IPOs and more than 440 mergers and acquisitions. ...
Anavasi just completed a $6.0 million Seed Round (convertible note), a $2.6 million Founder's Round and is preparing for a Q1 2022 Series A announcement. ...
IRVINE, Calif. – OCT. 4, 2022 – AIVITA Biomedical, Inc., a biotech company specializing in innovative cell applications, today announced that the Journal of Oncology Research and Therapy has published data from its completed Phase 2 glioblastoma (GBM) study which demonstrates enhanced progression-free survival (PFS). The publication, titled “Enhanced Progression-Free Survival in ...
Having invested in Araris’ seed round, we are now delighted to co-lead the latest round to ensure that Araris can unlock the potential of its differentiated technology and bring highly effective therapies to patients across the ...
VIC carefully selects and licenses technologies from universities and research institutions worldwide, then partners technology entrepreneurs with VIC’s business and technology experts and allocates seed capital through the national VIC Investor Network. In addition, VIC provides its portfolio companies with senior management expertise, extensive knowledge of technology ...
“Nex Cubed has a successful heritage of startup formation and acceleration for companies ranging from ideation to innovation, angel to seed, and growth to IPO. This enables us to work with companies at any stage, across the globe from the USA, Luxembourg, Singapore, Korea, Canada and beyond,” said Marlon Evans, CEO at Nex Cubed. ...
He also described how Linear Health conceived its development process and the path the company took to obtain its seed funding. “We’ve benefited from our ability to make the right fit at the right time with our medtech accelerator partnerships,” Clark said. ...
Isoray is a medical technology company and innovator in seed brachytherapy. The Company is the world’s only producer of Cesium-131 brachytherapy, commercially known as Cesium Blu, which is powering expanding internal radiation treatment options throughout the body for prostate cancer as well as difficult to treat lung, brain, gynecological, head and neck, pelvic, and ...
” “At M Ventures, we seed, support, and build transformational technologies that can significantly improve patient lives. ...
Research, production and marketing are the strengths of our company, and Smiling and Gesanbiotecno projects are an excellent opportunity to enhance the concept of integration between man, environment and technology. In Gesan, R&D department is a fundamental asset for the company’s business and all activities are constantly oriented towards the production and distribution of innovative ...
Microviable Therapeutics SL, a preclinical stage biotechnology company developing orally administered biological drugs based on microbiota-derived products, announced 1.5 million euros seed funding from the private medical group Inmunomet Intolerancia y Disbiosis SL. Microviable will use the seed funding to enhance their therapeutic development platform and ...
Patent and Trademark Office (USPTO) has granted a new patent (US 11,266,763 B2) that extends its key intellectual property to cover regeneration and repair of the bronchus due to cancer, injury or birth defects. Using a cell-seeded scaffold, which we call the Biostage Bronchial Implant, or BBI, we have performed the regeneration and repair of a bronchus (the airway that connects ...